Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2025)
Historic Research & Development for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $63.4 million.
- Amneal Pharmaceuticals' Research & Development rose 369.09% to $63.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.6 million, marking a year-over-year increase of 1264.74%. This contributed to the annual value of $190.7 million for FY2024, which is 1632.45% up from last year.
- According to the latest figures from Q3 2025, Amneal Pharmaceuticals' Research & Development is $63.4 million, which was up 369.09% from $48.0 million recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Research & Development ranged from a high of $63.4 million in Q3 2025 and a low of $36.1 million during Q2 2024
- Its 5-year average for Research & Development is $47.6 million, with a median of $48.2 million in 2021.
- In the last 5 years, Amneal Pharmaceuticals' Research & Development crashed by 2672.07% in 2023 and then surged by 4766.65% in 2024.
- Quarter analysis of 5 years shows Amneal Pharmaceuticals' Research & Development stood at $51.9 million in 2021, then dropped by 19.21% to $41.9 million in 2022, then increased by 9.97% to $46.1 million in 2023, then grew by 17.75% to $54.3 million in 2024, then grew by 16.75% to $63.4 million in 2025.
- Its last three reported values are $63.4 million in Q3 2025, $48.0 million for Q2 2025, and $40.0 million during Q1 2025.